Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Camber Capital Management LLC
10% owner at Protalix BioTherapeutics. Filing since 19 Oct 2015.
CIK 0001444043
Company
Date
Role
Action
Shares
Amount
Of holding
PLX
Protalix BioTherapeutics, Inc.
2 Dec 2016
10% owner
Sold, plan not stated
2,500,000
$792.00K
18.8%
PLX
Protalix BioTherapeutics, Inc.
19 Oct 2015
10% owner
Bought
4,000,423
$4.00M
43.1%
2 decisions on file.
